NO996580L - 5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat - Google Patents
5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleatInfo
- Publication number
- NO996580L NO996580L NO996580A NO996580A NO996580L NO 996580 L NO996580 L NO 996580L NO 996580 A NO996580 A NO 996580A NO 996580 A NO996580 A NO 996580A NO 996580 L NO996580 L NO 996580L
- Authority
- NO
- Norway
- Prior art keywords
- tetrazol
- ethyl
- methyl
- tetrahydropyridine
- maleate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK78197 | 1997-07-01 | ||
PCT/DK1998/000294 WO1999001448A1 (fr) | 1997-07-01 | 1998-07-01 | Maleate de 5-(2-ethyl-2h-tetrazole-5-yl)-1-methyle-1,2,3,6-tetrahydropyridine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO996580D0 NO996580D0 (no) | 1999-12-30 |
NO996580L true NO996580L (no) | 1999-12-30 |
Family
ID=8097489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO996580A NO996580L (no) | 1997-07-01 | 1999-12-30 | 5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0994869A1 (fr) |
JP (1) | JP2002507215A (fr) |
KR (1) | KR20010014297A (fr) |
CN (1) | CN1261361A (fr) |
AR (1) | AR013096A1 (fr) |
AU (1) | AU735751B2 (fr) |
BG (1) | BG103933A (fr) |
BR (1) | BR9810331A (fr) |
CA (1) | CA2293324A1 (fr) |
CO (1) | CO4940483A1 (fr) |
EA (1) | EA200000081A1 (fr) |
HU (1) | HUP0002876A2 (fr) |
IL (1) | IL133093A0 (fr) |
IS (1) | IS5278A (fr) |
JO (1) | JO2031B1 (fr) |
MA (1) | MA25138A1 (fr) |
NO (1) | NO996580L (fr) |
PE (1) | PE116099A1 (fr) |
PL (1) | PL337184A1 (fr) |
SK (1) | SK187399A3 (fr) |
TN (1) | TNSN98120A1 (fr) |
TR (1) | TR199903283T2 (fr) |
UY (2) | UY25069A1 (fr) |
WO (1) | WO1999001448A1 (fr) |
ZA (1) | ZA985498B (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
TR199800801T2 (xx) * | 1995-11-06 | 1998-08-21 | H. Lund-Beck A/S | Travmatik beyin yaralanmalar�n�n tedavisi. |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/fr not_active Withdrawn
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 CA CA002293324A patent/CA2293324A1/fr not_active Abandoned
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/xx unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Application Discontinuation
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/fr not_active Application Discontinuation
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE116099A1 (es) | 1999-11-23 |
JP2002507215A (ja) | 2002-03-05 |
CO4940483A1 (es) | 2000-07-24 |
BG103933A (en) | 2000-07-31 |
CA2293324A1 (fr) | 1999-01-14 |
IS5278A (is) | 1999-11-30 |
AR013096A1 (es) | 2000-12-13 |
SK187399A3 (en) | 2000-06-12 |
NO996580D0 (no) | 1999-12-30 |
HUP0002876A2 (hu) | 2001-06-28 |
CN1261361A (zh) | 2000-07-26 |
TR199903283T2 (xx) | 2000-06-21 |
AU735751B2 (en) | 2001-07-12 |
AU8102098A (en) | 1999-01-25 |
JO2031B1 (en) | 1999-05-15 |
BR9810331A (pt) | 2000-09-05 |
MA25138A1 (fr) | 2001-04-02 |
PL337184A1 (en) | 2000-08-14 |
EP0994869A1 (fr) | 2000-04-26 |
UY25069A1 (es) | 1998-12-21 |
WO1999001448A1 (fr) | 1999-01-14 |
UY25177A1 (es) | 2000-12-29 |
EA200000081A1 (ru) | 2000-08-28 |
ZA985498B (en) | 1999-01-20 |
IL133093A0 (en) | 2001-03-19 |
KR20010014297A (ko) | 2001-02-26 |
TNSN98120A1 (fr) | 2005-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE203019T1 (de) | Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane | |
JO3404B1 (ar) | تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين | |
BG103297A (en) | Aralkyl and aralkyliden heterocyclic lactams and imides | |
DE69307340D1 (de) | Chinuclidin derivat als substanz p antagonist | |
HK1008819A1 (en) | Piperidine derivatives as neurokinin antagonists | |
NO985977L (no) | Spiro-piperidinderivater og deres anvendelse som terapeutiske midler | |
EP0896533A4 (fr) | Pentafluorobenzenesulfonamides et analogues | |
CA2129995A1 (fr) | Derives thiacycliques de piperidinyle | |
TR200101962T2 (tr) | Sindirim sistemi bozukluklarını tedavi etmek için 4-(aminometil)-piperidin benzamidler | |
DE69941255D1 (de) | Verbindungen mit wachstumshormon freisetzenden eigenschaften | |
AU4310097A (en) | Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists | |
PT615751E (pt) | Utilizacao de antagonistas de taquinina no tratamento da emese | |
TNSN96174A1 (fr) | Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant. | |
BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
FI943499A0 (fi) | Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja | |
DE69925270D1 (de) | Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten | |
NO975681L (no) | Benzisoxazol- og indazol-derivater som antipsykotiske midler | |
BR9811821A (pt) | 2-acilaminopropanaminas como antagonistas de receptores de taquicinina | |
WO2002005801A3 (fr) | Compositions pharmaceutiques et procedes d'utilisation de ces dernieres | |
BG103306A (en) | Liquid allendronate compositions | |
WO1996031208A3 (fr) | Utilisation de composes de piperidine ou de pyrrolidine substitues pour le traitement de maladies modulees par un recepteur sigma | |
DE69514100D1 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel | |
NO996580L (no) | 5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat | |
EA199700032A1 (ru) | Дезинфицирующий состав "велтолен" | |
CA2217463A1 (fr) | Utilisation de la sulbutiamine pour l'obtention de compositions pharmaceutiques utiles dans le traitement de certains troubles psychomoteurs et psycho-intellectuels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |